ARVO 2015 Annual Meeting Abstracts 518 Clinical studies in ocular
... of Diseases, 9th Edition (ICD9) codes used in the Pacific Ocular Inflammation Study, a population-based study using the electronic medical records of Kaiser Permanente Hawaii to investigate the epidemiology of ocular inflammatory disease in the Hawaiian islands. Methods: The electronic record system ...
... of Diseases, 9th Edition (ICD9) codes used in the Pacific Ocular Inflammation Study, a population-based study using the electronic medical records of Kaiser Permanente Hawaii to investigate the epidemiology of ocular inflammatory disease in the Hawaiian islands. Methods: The electronic record system ...
ASSESSING THE VALUE OF BIOPHARMACEUTICAL INNOVATION
... There was a golden age of innovation in new classes of effective treatments for serious cardiovascular diseases over the years 1970-1995. Notably advances for treating angina, hypertension, hypercholesteraemia and heart failure. In each case a range of closely related innovative active agents have b ...
... There was a golden age of innovation in new classes of effective treatments for serious cardiovascular diseases over the years 1970-1995. Notably advances for treating angina, hypertension, hypercholesteraemia and heart failure. In each case a range of closely related innovative active agents have b ...
Cyanoacrylates for Skin Closure
... judged by blinded observers. The same authors also evaluated infection rates of contaminated seconddegree burns in pigs treated similarly [33]. Eighty partial-thickness burns were created and contaminated with 0.1 mL of S aureus 10(5) CFU/mL and then randomly treated with 2-OCA, SSD, PU, or gauze. T ...
... judged by blinded observers. The same authors also evaluated infection rates of contaminated seconddegree burns in pigs treated similarly [33]. Eighty partial-thickness burns were created and contaminated with 0.1 mL of S aureus 10(5) CFU/mL and then randomly treated with 2-OCA, SSD, PU, or gauze. T ...
Strimvelis, Common name - autologous CD34+ - EMA
... outcomes are less favourable in the majority of patients for whom matched related donors are not available. When patients are treated with cells from less well matched donors, the main risk is graft versus host disease (GvHD), a situation where the donor graft recognises the patient as foreign and m ...
... outcomes are less favourable in the majority of patients for whom matched related donors are not available. When patients are treated with cells from less well matched donors, the main risk is graft versus host disease (GvHD), a situation where the donor graft recognises the patient as foreign and m ...
If you Google Auto-Immune disease, you`ll find that it is a process
... It is important to understand that an autoimmune disease is a ‘state’ that the immune system is in. It is NOT a disease of an organ; and even though it is given a multitude of names depending on the tissue currently affected, it is a STATE of the immune system attacking the tissue it was meant to pr ...
... It is important to understand that an autoimmune disease is a ‘state’ that the immune system is in. It is NOT a disease of an organ; and even though it is given a multitude of names depending on the tissue currently affected, it is a STATE of the immune system attacking the tissue it was meant to pr ...
The Pharmacology and Management of the Vitamin K Antagonists
... gery, to allow the INR to return to normal, and beginning therapy with full-dose unfractionated heparin or full-dose low-molecular-weight heparin as the INR falls (Grade 2C). In patients undergoing dental procedures, we suggest the use of tranexamic acid mouthwash (Grade 2B) or epsilon amino caproic ...
... gery, to allow the INR to return to normal, and beginning therapy with full-dose unfractionated heparin or full-dose low-molecular-weight heparin as the INR falls (Grade 2C). In patients undergoing dental procedures, we suggest the use of tranexamic acid mouthwash (Grade 2B) or epsilon amino caproic ...
and i`m determined to fight
... Treatment of disease using high-energy waves or streams of particles called radiation. Chemotherapy A certain group of drugs used to treat patients with cancer. ...
... Treatment of disease using high-energy waves or streams of particles called radiation. Chemotherapy A certain group of drugs used to treat patients with cancer. ...
metronidazole injection usp
... maintained on phenytoin were found to have toxic blood levels after oral metronidazole administration. Phenytoin concentration returned to therapeutic blood level after discontinuance of metronidazole. The metabolism of metronidazole has been reported to be increased by concurrent administration of ...
... maintained on phenytoin were found to have toxic blood levels after oral metronidazole administration. Phenytoin concentration returned to therapeutic blood level after discontinuance of metronidazole. The metabolism of metronidazole has been reported to be increased by concurrent administration of ...
Allergic conjunctivitis: a comprehensive review of the literature Open Access
... of these agents. When avoidance of non-pharmacologic strategies do not provide adequate symptom relief, pharmacologic treatments may be applied topically or given systemically to diminish the allergic response. The mainstay of the management of ocular allergy involves the use of anti-allergic therap ...
... of these agents. When avoidance of non-pharmacologic strategies do not provide adequate symptom relief, pharmacologic treatments may be applied topically or given systemically to diminish the allergic response. The mainstay of the management of ocular allergy involves the use of anti-allergic therap ...
Allergic conjunctivitis: a comprehensive review of the literature
... of these agents. When avoidance of non-pharmacologic strategies do not provide adequate symptom relief, pharmacologic treatments may be applied topically or given systemically to diminish the allergic response. The mainstay of the management of ocular allergy involves the use of anti-allergic therap ...
... of these agents. When avoidance of non-pharmacologic strategies do not provide adequate symptom relief, pharmacologic treatments may be applied topically or given systemically to diminish the allergic response. The mainstay of the management of ocular allergy involves the use of anti-allergic therap ...
Asthma
... short-acting bronchodilators. Symptoms often vary seasonally or are associated with specific triggers, such as cold, exercise, animal dander, pollen, occupational exposures, certain foods, and aspirin or nonsteroidal anti-inflammatory drugs. Clinicians should also consider asthma in patients with ch ...
... short-acting bronchodilators. Symptoms often vary seasonally or are associated with specific triggers, such as cold, exercise, animal dander, pollen, occupational exposures, certain foods, and aspirin or nonsteroidal anti-inflammatory drugs. Clinicians should also consider asthma in patients with ch ...
Seroprevalence of Mycoplasma pneumoniae in HIV
... AIDS is clinically defined as the stage when an HIV-infected person’s CD4+ lymphocyte count falls below 200 per microlitre or the HIV-infected person has any of the AIDSdefining clinical illnesses. Mycoplasmal infection is highly significant clinically in AIDS, even if it is only one example of an o ...
... AIDS is clinically defined as the stage when an HIV-infected person’s CD4+ lymphocyte count falls below 200 per microlitre or the HIV-infected person has any of the AIDSdefining clinical illnesses. Mycoplasmal infection is highly significant clinically in AIDS, even if it is only one example of an o ...
Treatment of Axillary Hyperhidrosis
... chemicals can be irritating to the delicate armpit skin and require continuous usage. Topical anticholinergics and tannic acids produce only mixed effectiveness and suffer from the same lack of permanence. Glutaraldehyde, occasionally employed for palmar and plantar hyperhidrosis, is too irritating ...
... chemicals can be irritating to the delicate armpit skin and require continuous usage. Topical anticholinergics and tannic acids produce only mixed effectiveness and suffer from the same lack of permanence. Glutaraldehyde, occasionally employed for palmar and plantar hyperhidrosis, is too irritating ...
Gadolinium-Based Contrast Exposure, Nephrogenic Systemic
... was known to have received treatment at multiple institutions and may have received GBCAs elsewhere. Sensitivity for this test was 86%; specificity, 88%; and likelihood ratio, 6.9, with a 95% CI of 1.07–43.97. Interestingly, in one NSF patient (patient 7), gadolinium was detected not only in a typic ...
... was known to have received treatment at multiple institutions and may have received GBCAs elsewhere. Sensitivity for this test was 86%; specificity, 88%; and likelihood ratio, 6.9, with a 95% CI of 1.07–43.97. Interestingly, in one NSF patient (patient 7), gadolinium was detected not only in a typic ...
Urticaria: Evaluation and Treatment
... Second-generation antihistamines are considered first-line therapy. For better symptom control, the medication should be dosed daily, rather than on an as-needed basis.20 Treatment guidelines suggest that if normal doses are not successful, titration up to two to four times the usual dose is the nex ...
... Second-generation antihistamines are considered first-line therapy. For better symptom control, the medication should be dosed daily, rather than on an as-needed basis.20 Treatment guidelines suggest that if normal doses are not successful, titration up to two to four times the usual dose is the nex ...
Serological Response to Treatment of Syphilis
... courses have been reported. Although the clinically defined treatment response does not seem to be influenced by HIV coinfection, serologically defined treatment failure has been reported [4]. This might be a consequence of slower Venereal Disease Laboratory Research (VDRL) test seroreversion in HIV-in ...
... courses have been reported. Although the clinically defined treatment response does not seem to be influenced by HIV coinfection, serologically defined treatment failure has been reported [4]. This might be a consequence of slower Venereal Disease Laboratory Research (VDRL) test seroreversion in HIV-in ...
Review Article - "The Therapeutic Role of Ursodeoxycholic Acid in
... Patients in early histologic stage of PBC (I or II) on liver biopsy who are treated with UDCA have the best outcomes and have been shown to have survival rates similar to control populations without PBC.8,9 In treated patients, survival rates are better than rates predicted by the Mayo model.810 ...
... Patients in early histologic stage of PBC (I or II) on liver biopsy who are treated with UDCA have the best outcomes and have been shown to have survival rates similar to control populations without PBC.8,9 In treated patients, survival rates are better than rates predicted by the Mayo model.810 ...
March 2013 Medical Policy Updates
... received FDA approval. Available studies have demonstrated increased adverse events with the posterior approach. The safety and effectiveness of INFUSE Bone Graft in the cervical spine have not been demonstrated. There is insufficient clinical evidence to support the use of INFUSE Bone Graft with de ...
... received FDA approval. Available studies have demonstrated increased adverse events with the posterior approach. The safety and effectiveness of INFUSE Bone Graft in the cervical spine have not been demonstrated. There is insufficient clinical evidence to support the use of INFUSE Bone Graft with de ...
Targeting fibromyalgia pain: brain–spinal cord and peripheral
... The use of research-based classification criteria has resulted in considerable insight into FM [3] and the use of different diagnostic criteria aids diagnosis in the clinic [4] . All criteria for FM rely only on clinical history and examination. In all societies studied it has a high prevalence and ...
... The use of research-based classification criteria has resulted in considerable insight into FM [3] and the use of different diagnostic criteria aids diagnosis in the clinic [4] . All criteria for FM rely only on clinical history and examination. In all societies studied it has a high prevalence and ...
Arthrogryposis: Diagnosis and Therapeutic Planning for Patients
... Robinson45 described a high proportion of major feeding difficulties in infants when individuals with AMC were studied. These difficulties were related to structural abnormalities of the jaw and tongue. In this work, the author suggested that early identification of children with AMC is necessary an ...
... Robinson45 described a high proportion of major feeding difficulties in infants when individuals with AMC were studied. These difficulties were related to structural abnormalities of the jaw and tongue. In this work, the author suggested that early identification of children with AMC is necessary an ...
Hemophilia PPT
... genetic disease did not stop him from ending slavery and improving the country. He was still a good president, and did not die because of his hemophilia (he was assassinated). Lincoln also had a family, and led our country for a little over one term (killed in office in term two). Abraham Lincoln al ...
... genetic disease did not stop him from ending slavery and improving the country. He was still a good president, and did not die because of his hemophilia (he was assassinated). Lincoln also had a family, and led our country for a little over one term (killed in office in term two). Abraham Lincoln al ...
AFA 11th Edition TEXT_FINAL sequence.indd
... enzyme-linked immunosorbent assay, or ELISA. Screening ELISAs include a test for P24 antigen, which enables early diagnosis of HIV before antibodies are produced. Although the HIV ELISA has 100% sensitivity (no false negatives – but see notes on the “window period” below) it has a specificity of 99.7 ...
... enzyme-linked immunosorbent assay, or ELISA. Screening ELISAs include a test for P24 antigen, which enables early diagnosis of HIV before antibodies are produced. Although the HIV ELISA has 100% sensitivity (no false negatives – but see notes on the “window period” below) it has a specificity of 99.7 ...
Clinical presentation and diagnosis of brain tumors
... Patients who present with seizures usually have smaller primary brain tumors or fewer metastatic lesions in the brain, compared to those who present with other symptoms. This is probably because the diagnosis of a seizure is an indication for neuroimaging, which leads to an earlier diagnosis. (See " ...
... Patients who present with seizures usually have smaller primary brain tumors or fewer metastatic lesions in the brain, compared to those who present with other symptoms. This is probably because the diagnosis of a seizure is an indication for neuroimaging, which leads to an earlier diagnosis. (See " ...
Optimal Asthma Management - Dartmouth
... Both pivotal studies show that Omalizumab reduces asthma exacerbations requiring steroid interventions These reductions are statistically significant, robust to alternate analyses, and clinically relevant to patients with moderate to severe asthma All other endpoints are positive, including daytime ...
... Both pivotal studies show that Omalizumab reduces asthma exacerbations requiring steroid interventions These reductions are statistically significant, robust to alternate analyses, and clinically relevant to patients with moderate to severe asthma All other endpoints are positive, including daytime ...
Management of multiple sclerosis
Several therapies for multiple sclerosis (MS) exist, although there is no known cure. Multiple sclerosis is a chronic inflammatory demyelinating disease that affects the central nervous system (CNS).The most common initial course of the disease is the relapsing-remitting subtype, which is characterized by unpredictable attacks (relapses) followed by periods of relative remission with no new signs of disease activity. After some years, many of the people who have this subtype begin to experience neurologic decline without acute relapses. When this happens it is called secondary progressive multiple sclerosis. Other, less common, courses of the disease are the primary progressive (decline from the beginning without attacks) and the progressive-relapsing (steady neurologic decline and superimposed attacks). Different therapies are used for patients experiencing acute attacks, for patients who have the relapsing-remitting subtype, for patients who have the progressive subtypes, for patients without a diagnosis of MS who have a demyelinating event, and for managing the various consequences of MS.The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. As with any medical treatment, medications used in the management of MS may have several adverse effects, and many possible therapies are still under investigation. At the same time different alternative treatments are pursued by many patients, despite the paucity of supporting, comparable, replicated scientific study.This article focuses on therapies for standard MS; borderline forms of MS have particular treatments that are excluded.